What is CStone Pharmaceuticals's contact information?

CStone Pharmaceuticals's contact information: +862161097678.

How many employees does CStone Pharmaceuticals have?

CStone Pharmaceuticals has 300 employees.

What industry does CStone Pharmaceuticals belong to?

CStone Pharmaceuticals is in the industry of: Pharmaceutical Manufacturing, Internet.

What are CStone Pharmaceuticals's official social media profiles?

CStone Pharmaceuticals Linkedin Page

What tech stack does CStone Pharmaceuticals use?

Some of the popular technologies that CStone Pharmaceuticals uses are: Baidu Analytics, jQuery, Swiper, OWL Carousel, Slick, PHP.

What are CStone Pharmaceuticals's office addresses?

CStone Pharmaceuticals has a known office at the following address: 21/F, No. 399, West Haiyang Road, New Bund Times Square, Pudong New Area Shanghai, CN.

What is CStone Pharmaceuticals's estimated annual revenue?

CStone Pharmaceuticals's revenue is $9,539,000

What is CStone Pharmaceuticals's open headcount?

CStone Pharmaceuticals has no job postings yet.

What is the number of ad campaigns for CStone Pharmaceuticals?

CStone Pharmaceuticals has no advertisements yet.

What is the number of recent news articles about CStone Pharmaceuticals?

CStone Pharmaceuticals has 14 news articles.

CStone Pharmaceuticals - Pubrio Company Profile & Intent

CStone Pharmaceuticals

China · Pharmaceutical Manufacturing

Pharmaceutical Manufacturing

Internet

CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received ten NDA approvals for four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone's vision is to be a pioneer in enhancing global patient health through innovation.